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ABSTRACT 
PREDICTING DNA METHYLATION STATE OF CPG DINUCLEOTIDE 
USING GENOME TOPOLOGICAL FEATURES AND DEEP NETWORKS 
by Yiheng Wang 
May 2016 
The hypo- or hyper-methylation of the human genome is one of the 
epigenetic features of leukemia. However, experimental approaches have only 
determined the methylation state of a small portion of the human genome. I 
developed a deep learning based (stacked denoising autoencoders, or SdA) 
software named “DeepMethyl” to predict the methylation state of DNA CpG 
dinucleotides using features inferred from three-dimensional genome topology 
(based on Hi-C) and DNA sequence patterns. I used the experimental data from 
immortalized myelogenous leukemia (K562) and healthy lymphoblastoid 
(GM12878) cell lines to train the learning models and assess prediction 
performance. I have tested various SdA architectures with different configurations 
of hidden layer(s) and amount of pre-training data and compared the 
performance of deep networks relative to support vector machines (SVM). Using 
the methylation states of sequentially neighboring regions as one of the learning 
features, SdA achieved a blind test accuracy of 89.7% for GM12878 and 88.6% 
for K562. When the methylation states of sequentially neighboring regions are 
unknown, the accuracies are 84.82% for GM12878 and 72.01% for K562. I also 
analyzed the contribution of genome topological features inferred from Hi-C. 
DeepMethyl can be accessed at http://dna.cs.usm.edu/deepmethyl/. 
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CHAPTER I 
INTRODUCTION 
DNA methylation represents the addition of a methyl group to the fifth 
carbon of the cytosine or adenine1. DNA methylation occurs more frequently at 
CpG sites, where a guanine nucleotide follows a cytosine nucleotide in the 
sequence of the genome2,3. In some regions, the frequency of CpG sites is up to 
10 times greater than the average. These regions are called CpG islands 
(CGIs)4. CpG islands have a GC percentage greater than 50% with at least 200 
base pairs long. Generally speaking, CpG sites outside the CGIs are mostly 
methylated, whereas CpG sites within CGIs are mostly unmethylated5. This 
difference indicates that CGIs usually have distinguished patterns of methylation, 
which may be important in gene regulation or gene mutation6,7. 
DNA methylation has been found to have influences on the expression of 
gene and functional regulation of proteins8,9. According to recent studies10-12, 
DNA methylation can affect the onset and progress of various cancers and 
complex diseases. There are more methylated promoters and suppressors found 
in abnormal cell lines13. The aberrance of DNA methylation is one of the typical 
features of cancers such as acute myeloid leukemia14. However, the mechanistic 
link between aberrance of DNA methylation and leukemia is not well understood. 
Recent studies investigated DNA methylation in various cancers such as breast 
cancer15,16. The results indicate that abnormal DNA methylation usually occurs at 
some specific genomic locations17,18. 
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Recent advances in methylation sequencing technologies allow the 
identification of genome-wide methylated sites in DNA19,20. One way of profiling 
methylation patterns of DNA is via the use of bisulfite treatment of DNA followed 
by next-generation sequencing, which is known as bisulfite sequencing21. The 
current bisulfite sequencing methods include whole-genome bisulfite sequencing 
(WGBS)22 and reduced representation bisulfite sequencing (RRBS)23. Comparing 
to WGBS, RRBS reduces the amount of sequencing by using representative 
fractions of the genome. Therefore, RRBS specifically profiles and analyzes the 
methylation pattern for the regions with a high CpG content24.  
Methods have been developed to predict the methylation states at CpG 
sites, windows or segments of a genome25-28. Most of the current methods for 
methylation prediction assume that the methylation states are binary classes, 
that is, a CpG site or a window is either methylated or un-methylated 
(methylation-resistant)29. However, some other methods classified the 
methylation level to multiple classes30. Among these methods, predictions were 
usually limited to specific regions such as CGIs28,31. Predictive features used by 
these methods included DNA composition32, GC content28, sequence patterns33, 
and methylation state of neighboring region30. Recent methods also used pseudo 
nucleotide composition to predict the methylations sites of a genome32,34. The 
DNA composition and methylation state of sequential neighbors are the two most 
common features among these methods30,33.  
One of the features that has not been used in predicting DNA methylation 
is chromosome interaction. The Hi-C technique enables the investigation of both 
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intra- and inter-chromosomal contacts in a genome35. The analysis of the 
genome at 1-1000 kilo-base resolution captures the overall genome spatial 
conformational arrangements. The 1 kilo-base resolution would further capture 
the contacts between the genes within the genome36. The Hi-C experiments cut 
the crosslink DNA with restriction enzyme and ligate them under extremely dilute 
conditions that favor intermolecular ligation. The experiments then purify and 
shear the ligated DNA segments to obtain paired-end reads. The paired-end Hi-C 
reads are mapped to the reference genome. After mapping, the data are binned 
and normalized into the Hi-C contacts library, which indicates that certain 
positions are spatially close in the three-dimensional space.  
Although many methods have been developed to predict the methylation 
state of specific regions, the prediction of the methylation state of CpG sites in 
the loci of long non-coding RNAs (lncRNA) has received little attention. LncRNA 
are transcripts of non-coding genes ranging from 200 bases to 100 kilo-bases 
(kb) 37, yet their potential activities in human diseases have not been significantly 
unveiled. Recent studies on gene expression indicate that lncRNA may function 
as the connector between DNA and specific chromatin remodeling activities38, 
and the expression level of lncRNA usually is lower than the ones of protein-
coding genes39. Furthermore, lncRNA expression might be a main factor in 
carcinogenesis40. The exact mechanism of how lncRNAs influence cancer is 
unknown, but abnormal lncRNA expression may be a factor causing cancer by 
affecting major genetic processes. I evaluated my methylation predictions on the 
CpG sites in lncRNA loci.  
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In this study, I applied a deep learning algorithm, stacked denoising 
autoencoders (SdA), to predict DNA methylation status of CpG sites. Different 
from traditional learning algorithms, the training of SdA contains two stages: an 
unsupervised pre-training stage using unlabeled training data and a supervised 
fine-tuning stage using labeled data (data with known target values). I used 
sequential features generated within a window of the genome and features 
generated from the three-dimensional topology of a genome indicated by the Hi-
C experiment41. I did extensive tests of my method through several benchmarks. 
In the first benchmark (Benchmark 1), I included the methylation level of 
sequential neighboring regions as features, whereas in the second benchmark 
(Benchmark 2), I excluded this type of features to increase prediction difficulty. I 
also benchmarked the influences of unlabeled data in deep learning and the 
influences of the genome topological features on the prediction accuracy.  
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CHAPTER II 
RESULTS 
Overview 
I built SVM and SdA models to predict binary DNA methylation status of 
CpG sites (methylated or unmethylated). I applied my predictive models on 
lymphoblastic cell lines (GM12878) and chronic myelogenous leukemia cell lines 
(K562) to compare the performance of predictions on the healthy and cancer cell 
lines. Two types of windows were defined to generate features from sequentially 
and topologically neighboring regions of the genome (details see Methods). To 
better understand the factors influencing the performance of SdA, I applied 
different amounts of unlabeled pre-training samples, hidden layers, numbers of 
denoising autoencoders in each layer, and pre-training and training epochs. I 
also tested the performance of predicting methylation states of the CpG sites in 
lncRNAs loci.  
In Benchmark 1, I measured the performance of my predictors using the 
metrics accuracy (Acc), specificity (Sp), sensitivity (Se), Matthews’s correlation 
coefficient (MCC), and Receiver Operating Characteristic (ROC) curve using 
leave-one-out cross-validation. For the blind test data, only test accuracy was 
applied to evaluate the performance of SdA and SVM models. Different window-A 
sizes of each target CpG site, from 500 to 1000 nt, were tested. The definition of 
window-A can be found in the Methods section.  
Moreover, I conducted Benchmark 2 by eliminating the features containing 
the methylation state of sequential neighboring regions but only using features of 
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(1) the methylation level of three-dimensional (3D) neighboring regions and (2) 
sequential composition patterns of the DNA sequence. In order to find the impact 
of the Hi-C based (3D genome topology) features, I tested the performance of 
using features generated from randomly selected windows that do not have any 
Hi-C contact to the target region. Different “Hi-C ranges” (from 10K to 50K) were 
used to benchmark the impact of including different amounts of Hi-C window-B 
(definition see Methods) features. In addition, I performed a blind test by 
randomly combining the samples from chromosome 1 with the ones from 
chromosome 21.  
Chromosome-wide Analysis of Methylation Patterns and  
Preparing Training and Testing data sets 
The methylated and unmethylated samples were defined based on 
parameters α and β (details see Methods). In order to balance my training 
dataset, I examined the distribution of PercentMeth (explained in Methods) 
values from RRBS experiments on chromosomes 1, 2 and 3 for GM12878 and 
K562 (Figure 1). I found that the majority of CpG sites were either hyper-
methylated or hypo-methylated. Specifically, for GM12878 on chromosomes 1, 2 
and 3, 67.73% of CpG sites have methylation level < 0.1 (hypo-methylated), and 
14.40% of CpG sites have methylation level > 0.9 (hyper-methylated). Similarly, 
for K562, 60.42% are hyper-methylated and 14.43% are hypo-methylated. Based 
on this analysis, in order to balance the number of samples in methylated and 
un-methylated classes for leave-one-out cross-validation and blind test, I set the 
threshold β to be 0.01 making about half (46.25%) of the samples labeled as un-
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methylated. The threshold α was set accordingly to ensure the number of 
methylated samples was equal to the one of un-methylated samples. In this way, 
most of the samples were labeled into one of the binary classes, and no sample 
was labeled twice.  
 
Figure 1. Distribution of DNA methylation levels on CpG sites for chromosomes 
1, 2 and 3 for GM12878 and K562 
Optimizing Stacked Denoising Autoencoders (Benchmark 1) 
The parameters of stacked denoising autoencoders include number of 
hidden layers, number of hidden units in each layer, pre-training learning rate, 
number of pre-training epochs, fine-tuning learning rate, and the maximum of 
training epochs. 
I optimized the parameters to obtain the best average performance on the 
individual test samples in every round of leave-one-out cross-validation (Table 1). 
In each round, one sample was chosen as the test sample, and the other 
samples were equally split into one training set and one validation set. The 
training set was also used for unsupervised pre-training of the SdAs. I found that 
8 
 
 
 
after the SdA architecture reached 23-500-500-2 (23 input unites, two hidden 
layers each with 500 hidden units, and two output nodes), the performance no 
longer changed when increasing the number of hidden layers and number of 
nodes in each layer. Therefore, the number of hidden layers was set to two, and 
the number of hidden units in each layer was set to 500 for the leave-one-out 
cross-validation and blind test. The setup of other parameters of SdA can be 
found in the Methods section. 
Table 1   
Performance of SdA for GM12878 on chromosome 21 under different numbers of 
hidden layers and different numbers of hidden units using leave-one-out cross-
validation. 
Number of 
hidden units 
and hidden 
layers 
200 200-200 500 500-500 500-500-
500 
Accuracy 0.889 0.891 0.896 0.935 0.935 
 
Leave-one-out Cross-validations for Support Vector Machine and  
Stacked Denoising Autoencoders (Benchmark 1) 
In order to compare the performance of SVM, leave-one-out cross-
validation was conducted on chromosomes 1 and 21 for GM12878 and K562 
with different window-A sizes (Figure 2). The output of the SVM classifier is a 
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continuous number. Thus, I defined a cutoff µ to classify the output to discrete 
classes (for details see Methods).  
 
Figure 2. Leave-one-out cross-validation performance of SVM with different 
window sizes, chromosomes, and cell lines: (A) prediction accuracy, (B) 
specificity, (C) sensitivity, and (D) Matthews’s correlation coefficient. 
By the comparison of accuracies (Figure 2A) and Matthew's correlation 
coefficient (Figure 2D) of the two cell lines on chromosome 21 (black and green 
line) and chromosome 1 (red and blue line), I found that the performance for 
GM12878 is better overall than the performance for K562 on both chromosomes 
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1 and 21 on SVM model. One of the reasons may be that the number of samples 
for GM12878 is higher than K562 (Table 2), resulting from the different Hi-C 
coverages in the two cell lines. The average number of Hi-C reads for each 
nucleotide on GM12878 (chromosome 1 with 1.415 and chromosome 21 with 
0.822) is higher than K562 (chromosome 1 with 0.371 and chromosome 21 with 
0.206). In Benchmark 1, I included all the window-Bs that have at least one Hi-C 
contact with window-A. A higher Hi-C coverage results in more samples having at 
least one Hi-C contact and a higher number of window-Bs on average for each 
target CpG site.  
Table 2  
Number of samples used in leave-one-out cross-validation on chromosomes 1 
and 21 for cell lines GM12878 and K562 with window size 600nt. 
Cell Line Chromosome Number of Samples 
GM12878 21 296 
K562 21 230 
GM12878 1 2616 
K562 1 1988  
 
For both K562 and GM12878, SVM achieves better performance on 
chromosome 21 than on chromosome 1 with most window sizes (Figure 2A, D). 
However, the average specificity of prediction for K562 chromosome 1 does not 
have a significant difference with prediction on chromosome 21 (Figure 2B). 
Together with the lower sensitivity on chromosome 1 (Figure 2C), it indicates that 
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the worse performance on chromosome 1 may be due to the worse performance 
on predicting true positive (methylated) samples. 
The ROC curves were generated for chromosome 21. I calculated the 
values in the ROC curves by varying the cutoff µ from -2 to 2 (Figure 3). There is 
not a common window size to obtain the best performance for all cell lines. 
Figure 3 suggests that 600 nt is the best window size for GM12878 chromosome 
21, which achieves an accuracy of 94.3%, Matthews’s correlation coefficient of 
0.886, specificity of 0.919, and sensitivity of 0.966 (based on Figure 2). For K562, 
800 nt is the best window size, which achieves an accuracy of 87.6%, 
Matthews’s correlation coefficient of 0.753, specificity of 0.848, and sensitivity of 
0.904. Table 3 summarizes the best performance that SVM achieves and the 
corresponding window sizes.  
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Table 3  
The best performance achieved from leave-one-out cross-validation using SVM 
on chromosomes 1 and 21 for cell lines GM12878 and K562. The threshold α 
was used to ensure equal number of samples in methylated class and un-
methylated class.  
Cell Line Chromosome α Window 
Size 
Acc Sp Se MCC 
GM12878 CHR1 0.55 500 0.900 0.894 0.905 0.800 
GM12878 CHR21 0.99 600 0.942 0.918 0.966 0.886 
K562 CHR1 0.07 600 0.823 0.863 0.784 0.649 
K562 CHR21 0.43 800 0.876 0.848 0.904 0.753 
 
 
 
Figure 3. ROC curves of leave-one-out cross-validation using SVM with different 
window sizes for (A) GM12878 and (B) K562. 
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To compare the performance between SdA and SVM, I conducted leave-
one-out cross-validations for SdA on chromosomes 1 and 21 with window size 
600nt (Table 4). On chromosome 21, SdA obtained a worse performance for 
GM12878 with an accuracy of 0.935 compared to SVM’s accuracy 0.943. 
However, on chromosome 1, the SdA model achieved a better performance with 
an accuracy of 0.885, which is higher than SVM’s 0.839. Table 4 shows that the 
number of samples in chromosome 1 (2,616) is about six times higher than the 
ones for chromosome 21 (296), which may be one of the reasons for the 
performance difference. This indicates that the SdA algorithm may need more 
training samples to achieve better performance, whereas the SVM algorithm can 
achieve a decent performance with a much smaller size of training data.  
Table 4 
Performance of leave-one-out cross-validation using SVM and SdA on 
chromosomes 1 and 21 for cell line GM12878 on the window size 600nt.  
Classifier Cell Line Chromosome Acc Number of 
Samples 
SdA GM12878 CHR21 0.934 296 
SVM GM12878 CHR21 0.942 296 
SdA GM12878 CHR1 0.885 2616 
SVM GM12878 CHR1 0.839 2616 
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Evaluating SVM and Stacked Denoising Autoencoders on 
 Blind Test Data Sets (Benchmark 1) 
I further evaluated the performance of SVM and SdA using two blind test 
data sets. The predictive models were trained using CpG sites on chromosomes 
1, 2, and 3 with different window sizes for both healthy (GM12878) and cancer 
(K562) cell lines. I used CpG sites on chromosomes 1, 2, and 3 as the training 
set because chromosomes 1, 2, and 3 are the largest three chromosomes in 
humans. The numbers of training samples associated with various window sizes 
are shown in Figure 4. All features for the SVM and SdA classifiers were 
generated from the same dataset. The CpG sites on chromosomes 21 and X 
were selected as two independent test sets, considering that chromosome 21 is 
a smaller chromosome and chromosome X can be inactivated by the lncRNAs 
called Xist for female42. It would be interesting to study the methylation pattern in 
X chromosome and compare it with chromosome 21.  
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Figure 4. Number of training samples generated from chromosomes 1, 2 and 3.  
Comparing to chromosome X, predictions on chromosome 21 for 
GM12878 achieved a better performance on most window sizes (Figures 5 and 
6). The difference may be due to the chromosome-specific methylation patterns. I 
explored the distribution of the methylation level on chromosomes 21 and X 
(Figures 7 and 8), which suggests that for both GM12878 and K562, methylation 
distributions on chromosome 21 share similar patterns with the distribution on 
chromosomes 1, 2, and 3 (Figure 1), which were used as the training data. For 
example, on chromosome 21, 51.98% of the CpG sites have a methylation level 
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< 0.1, and 15.44% of the CpG sites have methylation level >0.9 (Figure 7), which 
is similar to 67.73% and 14.40% in chromosomes 1, 2, and 3 (Figure 1), 
respectively. However, for GM12878 on chromosome X, CpG sites with 
methylation level < 0.1 take a much lower proportion, that is, 33.24% (Figure 8), 
which indicates that the methylation distribution in chromosome X is significantly 
different from the distribution in chromosomes 1, 2, 3 (training data set), and 21 
(the other test data set). 
 
Figure 5. (A) Accuracy of blind test on chromosome 21 using SdA and SVM. (B) 
Number of samples in the test dataset with different window sizes in 
chromosome 21. 
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Figure 6. (A) Accuracy of blind test on chromosome X using SdA and SVM. (B) 
Number of samples in the test dataset with different window sizes in 
chromosome X.  
 
 
Figure 7. DNA methylation level distribution on chromosome 21 for GM12878 
and K562 
18 
 
 
 
 
Figure 8. DNA methylation level distribution on chromosome X for GM12878 and 
K562. 
Predicting Methylation State of lncRNA loci (Benchmark 1) 
I investigated DNA methylation prediction for CpGs sites located within 
lncRNAs genes. I used the same training data set, which is the combination of 
CpG sites on chromosomes 1, 2, 3, and the test data set that contains the CpG 
sites within lncRNAs genes on chromosomes 21 and X.  
Benchmarking on chromosome 21 lncRNA loci: for both GM12878 and 
K562 on chromosome 21, predictions for CpG sites within lncRNAs (Figure 9) 
achieved better performance than the ones without region-specific limitation (that 
is, both CpG sites within lncRNA genes and outsides lncRNA genes) (Figure 5). 
Specifically, for K562, SdA reached the best accuracy of 0.977, while the best 
accuracy is 0.886 for predictions on all CpG sites. This improvement in accuracy 
may be because the methylation distribution patterns of chromosome 21 
lncRNAs are more similar to the training dataset (chromosomes 1, 2 and 3) as 
compared to the ones of all CpG sites. Thus, I explored the methylation patterns 
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of CpG sites within lncRNA on chromosome 21 (Figure 10). I found that 60.42% 
of the CpG sites within lncRNAs had a methylation level < 0.1 (Figure 10), which 
is closer to the training dataset’s 67.73% (Figure 1) than 51.98% in CpG sites 
without region-specific limitation (Figure 7). 
 
 
Figure 9. (A) Performance of SdA for the prediction of methylation for lncRNAs 
and CpG sites without region-specific limitation on chromosome 21. (B) Number 
of samples in the test dataset on different window sizes in chromosome 21.    
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Figure 10. DNA methylation level distribution of CpG sites within lncRNA on 
chromosome 21 for GM12878 and K562. 
Benchmarking on chromosome X lncRNA loci: furthermore, I found that 
the performance for lncRNAs genes of GM12878 on chromosome X is worse 
than the one on chromosome 21 (Figures 11 and 9). The difference of 
performance for GM12878 on chromosome 21 and X may result from the 
different characteristics of methylation for chromosomes 21 and X. Therefore, I 
explored the distributions of the methylation levels of lncRNAs for chromosomes 
21 and X (Figures 10 and 12). It can be found that for GM12878, the methylation 
distribution of chromosome 21 lncRNAs shares similar patterns with the 
methylation levels of all CpG sites (not only lncRNAs) in chromosomes 1, 2, and 
3,  which were used as the training data. Specifically, on chromosome 21, there 
are 61.57% of lncRNA CpG sites have a methylation level < 0.1 (Figure 10), 
which is similar to 67.73% on chromosomes 1, 2 and 3 (Figure 1). In contrast, on 
chromosome X, only 31.65% of the lncRNA CpG sites have a methylation level < 
0.1 (Figure 12), which indicates that the methylation distribution for lncRNA on 
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chromosome X is quite different from the training data set comprised of 
chromosomes 1, 2 and 3.  
 
 
Figure 11. (A) Performance of SdA for the prediction of methylation for lncRNAs 
and CpG sites without region-specific limitation on chromosome X. (B) Number of 
samples in the test dataset on different window sizes in chromosome X. 
 
 
 
Figure 12. DNA methylation level distribution of CpG sites within lncRNA on 
chromosome X for GM12878 and K562. 
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Moreover, since both K562 and GM12878 are samples from female, it is 
possible that the X chromosome may be inactivated or in the process of 
inactivation by an lncRNA called Xist42 that packs the three-dimensional structure 
of X chromosome to disable the expressions of most X-chromosome genes. The 
change of three-dimensional genome structure of X chromosome influences the 
genome structural based features used in my methods and may also alter the 
DNA methylation patterns in chromosome X. Moreover, another reason may be 
that the test dataset of X chromosome is relatively small, compared to the one of 
chromosome 21. Therefore, the influence of error becomes more significant 
(Figure 11 B). 
The Impact of Hi-C Based Genome Topological Features (Benchmark 2) 
Benchmark 1 used the methylation level of sequential neighboring region 
of a target CpG site. In Benchmark 2, I eliminated that feature in order to 
benchmark the performance only based on the sequence composition of window-
A and window-B (three-dimensional topological neighboring regions) in addition 
to methylation levels in window-B. Compared to Benchmark 1, I added 74 
PseTNC features for window-A and eight features for window B. All of these 
newly added features indicate sequence composition. In Benchmark 2, I used 
both up-sampling and down-sampling to balance training data. Details can be 
found in the Methods section. 
I also changed Hi-C based window-B to a randomly generated window-B 
in order to observe the impact of Hi-C inferred topological neighbors. I only used 
the randomly generated windows that do not have any Hi-C contact with the Hi-C 
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ranges (the region surrounding a target CpG site that Hi-C neighbors were 
collected from, see the Methods section for details). In this way, I eliminated 
topological neighbors from the random windows. Different sizes of Hi-C ranges 
were tested.  
Table 5 shows the 5-fold cross-validation accuracy and MCC scores of 
SVM on using both Hi-C based window-Bs and randomly selected windows. The 
performance on Hi-C based and random windows is similar in this case with 
random windows performing slightly worse.  Tables 6-11 show the performance 
of SdAs. I benchmarked one, two, and three hidden layer(s) and found that more 
hidden layers result in significantly worse performance for randomly selected 
windows.   
Table 5  
The SVM’s 5-fold cross-validation accuracy and MCC scores of using Hi-C based 
topological neighboring window-Bs and random window-Bs on chromosome 1 
with different Hi-C ranges. 
Hi-C range Acc (Hi-C based) Acc (random) MCC (Hi-C based) MCC random 
10K 0.831 0.828 0.616 0.600 
20K 0.833 0.810 0.618 0.584 
30K 0.830 0.815 0.614 0.586 
40K 0.837 0.832 0.623 0.606 
50K 0.838 0.824 0.628 0.601 
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Table 6 
The 5-fold cross-validation accuracies of SdA on chromosome 1 with different Hi-
C ranges.  
Hi-C range Hi-C_1L Random_1L Hi-C_2L Random_2L Hi-C_3L Random_3L 
10K 0.829 0.830 0.837 0.714 0.835 0.406 
20K 0.839 0.839 0.828 0.668 0.829 0.376 
30K 0.840 0.835 0.832 0.823 0.830 0.376 
40K 0.828 0.835 0.831 0.831 0.828 0.565 
50K 0.841 0.819 0.826 0.828 0.834 0.326 
 
Note. The SdA model was trained with 10 pre-training epochs (unsupervised learning, learning rate 0.01) and 100 fine-
tuning epochs (supervised learning, learning rate 0.01). The 1L, 2L and 3L are the number of hidden layers with 
corruption levels of all layers set to 0.1. All the layers have 100 hidden nodes. Features based on genome topological 
neighbors (window-Bs, indicated as “Hi-C” in the table) and features based on randomly selected regions (random 
windows, indicated as “Random” in the table) were used to benchmark the impact of Hi-C based features. 
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Table 7  
The MCC scores for the same set up as in Table 6 
Hi-C range Hi-C_1L Random_1L Hi-C_2L Random_2L Hi-C_3L 
Random
_3L 
10K 0.611 0.600 0.628 0.549 0.627 0.040 
20K 0.626 0.624 0.613 0.372 0.614 0.032 
30K 0.627 0.619 0.620 0.604 0.614 0.018 
40K 0.612 0.619 0.623 0.614 0.615 0.265 
50K 0.635 0.602 0.617 0.615 0.623 0.050 
 
Table 8  
The accuracy of the same SdA architectures as in Table 6 with pre-training 
epochs set to 10 and training epochs set to 10. 
 
Hi-C range Hi-C_1L Random_1L Hi-C_2L 
Random_2
L Hi-C_3L 
Random
_3L 
10K 0.794 0.795 0.777 0.6545 0.765 0.692 
20K 0.787 0.776 0.768 0.7117 0.796 0.682 
30K 0.793 0.773 0.768 0.766 0.798 0.712 
40K 0.795 0.778 0.778 0.7668 0.777 0.699 
50K 0.792 0.770 0.778 0.7807 0.789 0.777 
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Table 9  
The MCC of the same configuration as in Table 8. 
Hi-C range Hi-C_1L Random_1L Hi-C_2L 
Random_2
L 
Hi-C_3L 
Random
_3L 
10K 0.530 0.439 0.501 0.040 0.474 0.008 
20K 0.525 0.495 0.488 0.056 0.324 0.036 
30K 0.531 0.505 0.480 0.425 0.357 0.008 
40K 0.528 0.501 0.501 0.426 0.000 0.066 
50K 0.534 0.499 0.510 0.376 0.196 0.000 
 
Table 10 
The accuracy of the same SdA architectures as in Table 6 with pre-training 
epochs set to 100 and training epochs set to 10. 
Hi-C range Hi-C_1L Random_1L Hi-C_2L Random_2L Hi-C_3L 
Random_
3L 
10K 0.773 0.690 0.763 0.639 0.765 0.642 
20K 0.801 0.699 0.768 0.641 0.776 0.759 
30K 0.791 0.67 0.764 0.715 0.771 0.662 
40K 0.777 0.699 0.765 0.643 0.759 0.649 
50K 0.795 0.739 0.795 0.634 0.763 0.625 
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Table 11 
The MCC scores for the same configurations in Table 10. 
Hi-C range Hi-C_1L Random_1L Hi-C_2L Random_2L Hi-C_3L 
Random
_3L 
10K 0.484 0.003 0.493 -0.003 0.495 -0.04 
20K 0.375 0.044 0.508 -0.001 0.519 0.011 
30K 0.392 0.026 0.502 0.017 0.507 0.015 
40K 0.103 0.091 0.503 0.009 0.484 0.008 
50K 0.276 0.027 0.499 -0.003 0.494 -0.005 
 
In order to benchmark the influence of unsupervised pre-training of SdAs, 
I conducted three independent 5-fold cross-validations, in which the epochs of 
unsupervised pre-training and supervised training were set to (10, 100) (Tables 6 
and 7), (10, 10) (Tables 8 and 9), and (100, 10) (Tables 10 and 11) while unifying 
all the other factors, including pre-training, training, validation, and testing data 
and other SdA parameters. The results show that larger epochs for unsupervised 
pre-training and smaller epochs of supervised training may decrease 
performance and make the SdAs perform significantly worse for random 
windows. The epochs of unsupervised pre-training and supervised training of 
(10, 100) generated the best performance.  
Blind Test on Chromosome 21 and LncRNA Loci (Benchmark 2) 
I tested the performance on randomly combined samples from 
chromosomes 1 and 21 (details of data generation see Methods). For SdAs, the 
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epochs of unsupervised pre-training and supervised training was set to (10, 100), 
and the other parameters remained the same as the 5-fold cross-validation that 
generated the best results. Similar findings as in the 5-fold cross-validation were 
observed. That is, a higher number of hidden layers makes the SdA perform 
significantly worse on the random windows in GM12878 (Table 12). For K562, 
the SdA model achieved an accuracy of 72.01%. I also benchmarked the 
performance on the CpG sites without genome topological features (no Hi-C 
signals); and in this case, the accuracies of GM12878 and K562 are 84.25% and 
69.95%, respectively.  
Table 12 
The blind test accuracy and MCC scores for SdA and SVM on randomly 
combined training and testing samples from chromosomes 1 and 21 with Hi-C 
range 10K.  
Classifier Features SdA architecture Acc MCC 
SdA Hi-C based window-B  109-100-2 0.871 0.666 
SdA Random window-B  109-100-2 0.810  0.612 
SdA Hi-C based window-B  109-100-100-2 0.867 0.659 
SdA Random window-B  109-100-100-2 0.631 0.058 
SVM Hi-C based window-B  NA 0.860 0.685 
SVM Random window-B  NA 0.858 0.725 
 
Note. The ration of fine-tuning, validation, and testing samples for SdA is 3:1:1. With two hidden layers, the MCC score of 
SdA is 0.058. I found that the predictions are highly biased to negative samples. This causes the false negative to be a 
value close to 1. Therefore, it has a very low MCC score. 
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Using the optimized SdA configuration and SVM model found in the 5-fold 
cross-validations, I tested their performance on GM12878 chromosome 21 
lncRNA loci (Table 13). Two hidden layers of SdA generated the best testing 
accuracy that is similar to SVM. In terms of MCC score, two-hidden-layer SdA 
(0.6427) performed slightly better than SVM (0.6385).  
Table 13 
Performance of SdA and SVM for predicting methylation level of CpG sites within 
lncRNA regions.  
Classifier SdA architecture Acc MCC  Number of test 
samples 
SdA 109-100-2 0.796 0.5678  2138 (551 positive, 
1587 negative) 
SdA 109-100-100-2 0.784 0.5617  2138 
SdA 109-100-100-100-2 0.832 0.6427  2138 
SVM NA 0.837 0.6385  2138 
 
Note. The SdA architecture and SVM model used were the one with the best test accuracy in 5-fold cross-validation on 
chromosome 1 (Tables 6-11). The number of testing lncRNA samples are 2,138 (551 positive and 1587 negative). 
 
Benchmarking the Parallel Algorithm for Generating 
 Features and Training SVMs 
A parallel algorithm was used to reduce the execution time of the entire 
feature generation process. The parallel algorithm was implemented using C++ 
and MPICH, and the performance tests were conducted on my own shared 
memory server equipped with 48 CPUs with speed 1200 MHz and 126 gigabytes 
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of memory. A test result is given in Table 14, which shows that my parallel 
method dramatically saves computational time. 
Table 14 
Execution time (seconds) and corresponding Speedup (time of using one 
process divided by the time using x processors, x = 2, 4, 6, and 16) on 
chromosome 21 of K562. 
Number of  
Processes 
P=1 P=2 P=4 P=8 P=16 
Chr21 
Time 703.05 370.69 201.41 99.97 56.58 
Speedup - 1.89 3.49 7.03 12.43 
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CHAPTER III 
DISCUSSIONS 
I developed SVM and SdA models to predict binary methylation state of 
CpG sites on GM12878 and K562 on different chromosomes with different 
window sizes. In the leave-one-out cross-validation for SVM classifier, the 
accuracy reaches 0.943 on chromosome 21 of GM12878, while the accuracy 
reaches 0.876 on chromosome 21 of K562. The distinction of performance 
between GM12878 and K562 on the SVM model may result from the different 
numbers of samples and Hi-C coverage. This indicates that the Hi-C reads 
coverage plays an important role, as a higher Hi-C coverage can increase the 
resolution of the three-dimensional genome structure and provide more 
neighboring CpG sites as features for the machine learning models.  
Furthermore, I evaluated the SdA classifier using a leave-one-out cross-
validation. For SdA classifier tested on 296 CpG sites of GM12878 chromosome 
21, the accuracy reaches 0.935, which is slightly lower than SVM classifier’s 
0.943. However, on chromosome 1 for GM12878, in which the total number of 
leave-one-out samples reaches 6,516, the accuracy of SdA classifier reaches 
0.885, which is obviously higher than SVM classifier’s 0.839. The difference of 
performance between SVM and SdA may suggest that the SdA algorithm needs 
more training samples to achieve better performance. Moreover, by comparing 
the performance with features excluding methylation level of neighbors and GC 
contents, I found that, especially for SdA, neighboring methylation levels and GC 
content are influential to the prediction performance.   
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Moreover, I evaluated the performance of SVM and SdA classifiers using 
two blind test sets. My experiments used chromosomes 1, 2 and 3 as the training 
set, and chromosomes 21 and X as two independent test data sets. SdA reaches 
the best accuracy of 0.897 on chromosome 21 of GM12878 with window size 
500nt. On chromosome 21, both SVM and SdA have a stable performance over 
different window sizes for both K562 and GM12878. For chromosome X, SdA 
achieved a best accuracy of 0.880 for GM12878 with window size 900 nt. 
Overall, the accuracies of GM12878 on chromosome X are lower than the ones 
on chromosome 21 for most window sizes. This may be because the distributions 
on chromosome X are largely different from the distributions in the training 
dataset of chromosomes 1, 2, and 3.  
I investigated the performance of predicting the DNA methylation state for 
CpG sites within lncRNA DNA locus. The best accuracy, 0.977, was obtained 
when using SdA on chromosome 21 of K562 with window size 500nt. I further 
found that the performance on chromosome X was overall worse than the 
performance on chromosome 21. By analysis, I found that the methylation 
distribution of lncRNA genes in chromosome X of GM12878 was largely different 
from the distributions found in both chromosome 21 and the training 
chromosomes 1, 2, and 3. This may result from the existence of an lncRNA 
called Xist that packs and inactivates the chromosome X of female causing the 
different methylation patterns. My data indicates methylation patterns of lncRNA 
may be chromosome- and cell line-specific. 
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In order to benchmark the influence of Hi-C based genome topological 
features, I replaced Hi-C neighbors with randomly selected windows and then 
benchmarked the performance. I found that using random windows significantly 
decreased the performance of SdAs with two or more hidden layers. I also tested 
it with different numbers of epochs for pre-training and fine-tuning and found that 
a larger number of fine-tuning increases performance, whereas a larger number 
of pre-training decreases the performance. 
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CHAPTER IV 
METHODS 
Datasets 
Human cell lines: the cell lines GM12878 and K562 were selected for my 
study because of their accessibility and sufficient experimental data associated 
with them. GM12878 is a B-lymphocyte cell line from a female, while K562 is an 
immortalised cell line from a female patient with chronic myelogenous leukemia 
(CML) (for description of these two cell lines see 
http://www.genome.gov/26524238). Thus, investigating the methylation 
prediction on these two cell lines may help me characterize the methylation 
patterns of cancer and healthy cell lines. 
DNA methylation data: DNA methylation state at each CpG dinucleotide is 
measured by Reduced Representation Bisulfite Sequencing (RRBS) data. RRBS 
methylation data for cell lines GM12878 and K562 were obtained from the 
ENCODE project 
(http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeHaibM
ethylRrbs/).  
Genome topology: the Hi-C paired reads36 for GM12878 and K562 cell 
lines were obtained from the public accessible NCBI GEO database 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM1181867) and NCBI 
SRA database (accessible at 
http://sra.dnanexus.com/experiments/SRX011614/runs), respectively. The paired-
end Hi-C reads were mapped to the human reference genome (UCSC version 
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hg19) using the read sequence alignment tool Maq43. The contact library 
containing spatial contacts between pairs of genomic positions were generated 
by parsing the Maq mapping outputs. Each contact between two positions on 
genome implies that they are spatially proximate in three-dimensional structure.  
Support Vector Machines (SVM) 
There are four types of kernel functions in SVM-Light44: linear, polynomial, 
radial basis function, and sigmoid. In Benchmark 1, I selected the polynomial 
kernel function for my SVM classification model because this kernel function 
achieves the best performance based on the 23 features using leave-one-out 
cross-validation (data not shown). Based on the optimization of SVM model, the 
parameter C (trade-off between training error and margin) was set to 5, and the 
polynomial kernel function parameter d was set to 3. In Benchmark 2, the radical 
basis function was selected as the kernel function based on the cross-validations 
on 109 features. I used the default value of parameter C in SVM-light and set the 
parameter gamma in radical basis function to 9 based on optimization. 
Deep Learning - Stacked Denoising Autoencoder 
The deep learning architecture applied to this research is Stacked 
Denoising Autoencoder (SdA)45 implemented with Theano 
(http://deeplearning.net/software/theano/). Theano is a Python-based library 
enabled GPU-based high performance computing for deep networks. The SdA 
algorithm composed of two phases of learning. The first phase is unsupervised 
pre-training carried out by layers of denoising autoencoders, which learn a 
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reconstruction Z from corrupted version of data X by minimizing the cross-
entropy of the reconstruction: 
𝐿𝐻(𝑋, 𝑍) = −∑ [𝑋𝑘 𝑙𝑜𝑔 𝑍𝑘 + (1 − 𝑋𝑘)𝑙𝑜𝑔⁡(1 − 𝑍𝑘)]
𝑑
𝑘=1
                        (1) 
for all the training samples in a minibatch. The Z, which is the 
reconstruction of the corrupted version of data X, was computed from 
𝑍 = 𝑆(𝑊′𝑦 + 𝑏′)                                                                                                (2) 
where 𝑊′ is the reconstruction weighting matrix, 𝑏′ is the reconstruction 
bias, and function 𝑆() is a sigmoid function: 
𝑆(𝑡) = ⁡
1
1+⁡𝑒−𝑡
                                                                                                      (3) 
Also, Z, the reconstruction of the corrupted input X, can be considered as 
the prediction of X because it tries to have the same shape of X given y, where 
𝑦 = 𝑠(𝑊𝑥 + 𝑏)                                                                                                          (4)     
in which 𝑠() is a sigmoid function, W is the weighting matrix, and b is the 
bias. Formula 4 maps the corrupted input 𝑋⁡𝜖⁡[0, 1]𝑑 to a hidden 
representation⁡𝑦⁡𝜖⁡[0, 1]𝑑′, which is reversely mapped by Formula (2) to build a 
reconstruction of corrupted data X by minimizing Formula (1). The corrupted 
input X is a sparse version of the original input X-orig. There are multiple ways to 
generate X from X-orig, and I used a parameter called corruption level to set it. 
The hidden units in a hidden layer were randomly selected to be disabled from 
an input node based on the probability set by the corruption level parameter. This 
corrupted version of autoencoders does not only learn the identifiers of the input 
data but also learns the features that are more useful to the problem. Therefore, 
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it is also named denoising autoencoders46. This corruption process was applied 
in each layer of hidden units in stacked denoising autoencoders. 
The learning process computes the cost based on Formula (1) for each 
layer of stacked denoising autoencoders and updates the weights and biases by 
gradient descent. The training process starts from the first layer directly 
connecting to the input data, and continues layer by layer. The trained m layers 
enable the computation of latent representation in layer m+1. In this way, all 
stacked layers of denoising autoencoders were trained, and the outputs from 
these layers of denoising autoencoders are the reconstruction of input X-orig or 
the features selected from the original data. With that, the unsupervised pre-
tuning part is finished.  
A supervised fine-tuning is applied after the unsupervised pre-tuning. A 
logistic regression model was added on top of the layers of denoising 
autoencoders that calculates: 
P(Y = i|x,W, b) = softmaxi(Wx + b) = ⁡
𝑒𝑊𝑖𝑥+𝑏𝑖
∑ 𝑒
𝑊𝑗𝑥+𝑏𝑗
𝑗
         .                                (5) 
This formula calculates the probability of an input vector x having the class 
i of Y. W is the weighting matrix; b is the bias; and j can be all the possible 
classes in Y. After calculating the probabilities for all possible classes in Y, an 
input vector x is assigned or predicted to the class that gives highest probability 
as: 
𝑦𝑝𝑟𝑒𝑑 = 𝑎𝑟𝑔𝑚𝑎𝑥𝑖𝑃(𝑌 = 𝑖⁡|𝑥,𝑊, 𝑏) .                                                                             (6) 
A multilayer perceptron is constructed that shares the same number of 
layers, number of neurons in each layer, weight, and bias as previously trained 
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stacked denoising autoencoders. Label value Y was used to train the multilayer 
perceptron by a backpropagation algorithm with logistic function as activation 
function. In this way, the multilayer perceptron was trained, and the entire 
learning architecture was fine-tuned. Therefore, the weights and bias in each 
hidden layer of the deep network were updated again based on the class label y 
of each training sample.  
Based on my Benchmark 1 (see Results), the best configuration achieving 
optimal performance contains two hidden layers each with 500 hidden units; the 
pre-training learning rate and epochs were set as 0.01 and 100; the fine-tuning 
learning rate was set as 0.1; and the maximum of training epochs was set as 
1000. In Benchmark 2, the learning rates of pre-training and fine-tuning were set 
to 0.01; corruption level was set to 0.1 for all hidden layers. Different epochs for 
pre-training and fine-tuning were tested (see Results). The SdA algorithm was 
implemented on a NVIDIA Quadro K5100 GPU with 1,536 CUDA parallel 
processor cores. 
Machine Learning Features 
Overview: I defined two types of windows for each CpG site to generate 
features. The first type of window, window-A, is a DNA sequence window with the 
target CpG site as the center whose size varies from 500 to 1000nt. Window-A 
was used to generate features from the sequence that are immediately adjacent 
to the target CpG sites. The second type of window, window-B, is a sequence 
window with point X in the center, whereas point X and a point in window-A (for 
Benchmark 1) or “Hi-C range” (for Benchmark 2, definition see below) must be in 
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contact indicated by a Hi-C paired ends read. The coordinates of CpG sites and 
corresponding window sequences were determined based on human reference 
genome hg19. 
Features from window-A: there are four types of DNA nucleotides: adenine 
(A), thymine (T), guanine (G), and cytosine (C). Both the ratio and order of these 
four nucleotides indicate important features of the DNA sequence. Studies27,33 
have proved that the occurrence of certain DNA patterns may be related to the 
methylation level. Hence, for Benchmark 1, the ratios of A, T, G, C and eight 
specific fragments (sequential signatures, Table 15), which have been proven to 
be useful features for methylation prediction25, were used as features for my 
prediction. In some recent studies30, the methylation state of neighboring regions 
was incorporated as one of the features. Hence, the “percentMeth” values from 
RRBS experiments indicating averaged methylated percentage were gathered 
and averaged in window-A, and then were included as a type of feature in 
Benchmark 1.   
Table 15 
Features used for machine learning algorithms and their descriptions.  
Feature name Feature description Used in 
benchmark
: 
Ra_A Ratio of adenine in window-A 1, 2 
Ra_B Ratio of thymine in window-A 1, 2 
Ra_C Ratio of guanine in window-A 1, 2 
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Ra_D Ratio of cytosine in window-A 1, 2 
Pa_AAWGGR Pattern frequency of AAWGGR in 
window-A 
1, 2 
Pa_TGRAAT Pattern frequency of TGRAAT in 
window-A 
1, 2 
Pa_AAT Pattern frequency of AAT in window-A 1, 2 
Pa_ATGVAA Pattern frequency of ATGVAA in 
window-A 
1, 2 
Pa_ACG Pattern frequency of ACG in window-A 1, 2 
Pa_GC Pattern frequency of GC in window-A 1, 2 
Pa_CG Pattern frequency of CG in window-A 1, 2 
Pa_TG Pattern frequency of TG in window-A 1, 2 
Pa_CCGC Pattern frequency of CCGC in window-A 2 
Pa_CCCC Pattern frequency of CCCC in window-A 2 
Pa_CGCC Pattern frequency of CGCC in window-A 2 
Pa_AAAG Pattern frequency of AAAG in window-A 2 
Pa_CTCC Pattern frequency of CTCC in window-A 2 
Ave_ meth Average methylation level in window-A 1 
PseTNC 74 pseudo tri-nucleotide composition 
features (Detail see Methods) 
2 
Ave_meth_Hi_C Average methylation level in window-Bs 1, 2 
Ave_Ra_A_Hi_C Average Ra_A in window-Bs 1, 2 
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Ave_Ra_B_Hi_C Average Ra_B in window-Bs 1, 2 
Ave_Ra_C_Hi_C Average Ra_C in window-Bs 1, 2 
Ave_Ra_D_Hi_C Average Ra_D in window-Bs 1, 2 
Ave_Pa_AAWGGR_Hi
_C 
Average Pa_ AAWGGR in window-Bs 1, 2 
Ave_Pa_TGRAAT_Hi_
C 
Average Pa_ TGRAAT in window-Bs 1, 2 
Ave_Pa_AAT_Hi_C Average Pa_ AAT in window-Bs 1, 2 
Ave_Pa_ATGVAA_Hi_
C 
Average Pa_ ATGVAA in window-Bs 1, 2 
Ave_Pa_ACG_Hi_C Average Pa_ ACG in in window-Bs 1, 2 
Ave_Pa_CCGC _Hi_C Average Pa_CCGC in window-Bs 2 
Ave_Pa_CCCC _Hi_C Average Pa_CCCC in window-Bs 2 
Ave_Pa_CGCC _Hi_C Average Pa_CGCC in window-Bs 2 
Ave_Pa_AAAG _Hi_C Average Pa_AAAG in window-Bs 2 
Ave_Pa_CTCC _Hi_C Average Pa_CTCC in window-Bs 2 
Ave_Pa_GC _Hi_C Average Pa_GC in window-Bs 2 
Ave_Pa_CG _Hi_C Average Pa_CG in window-Bs 2 
Ave_Pa_TG _Hi_C Average Pa_TG in window-Bs 2 
 
Note. The feature names containing “Hi_C” were generated in window-B, that is, the topological neighbors indicated by 
Hi-C experiments. 
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For Benchmark 2, that is, the 5-fold cross-validation on chromosome 1 
and blind test on random combination of chromosomes 1 and 21, I incorporated 
more sequential features and eliminated the features indicating methylation level 
in neighboring region. As introduced by some recent publications47-62, some 
useful statistical features for biological systems have been developed and 
presented. These features include pseudo amino acid composition (PseAAC)63, 
pseudo k-tuple nucleotide composition (PseKNC) and pseudo trinucleotide 
composition (PseTNC)64. I implemented 74 PseTNC features as DNA sequence 
property features. The pseTNC (pseudo trinucleotide composition) is a statistical 
feature, which incorporates the occurrence frequencies of all the pseudo 
trinucleotide compositions. The features are defined as 
D = [𝑑1⁡𝑑2…𝑑64…⁡𝑑64+λ                   (7) 
in which the first 64 features measure the local or short-range sequence pattern 
and the next λ = 10 components measure the global effect. The 74 features were 
generated by incorporating the frequency and multiple physical properties of 
each pseudo trinucleotide composition. The detail of calculating these features 
can be found in the reference64. 
Features based on three-dimensional genome topology - Benchmark 1: 
for each target CpG site, I gathered all the Hi-C contact pairs with one end falling 
into the window-A region. Using the other Hi-C end as the center, a window-B 
was defined with the same size of window-A. I only included the window-Bs that 
are > 1000nt away from the target CpG sites ensuring they are sequentially a 
long-distance away but proximate in three-dimensional space. In this way, I 
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eliminated the methylation level of the sequentially neighboring region for a target 
CpG site. Because multiple Hi-C pairs may have one end falling into the window-
A region of each target CpG site, I usually gathered multiple window-Bs. The 
number of available window-Bs is influenced by the size of window-A and the Hi-
C reads coverage, which was calculated by: multiplying the length of Hi-C read 
by the number of Hi-C reads and then dividing by the total length of the reference 
genome. I benchmarked my performance with different sizes of window-A. For 
each window-B, I generated the DNA sequence properties (Table 15) and 
averaged methylation PercentMeth, and then averaged these values for multiple 
window-Bs. 
Benchmark 2: I eliminated the methylation level in window-A, but only kept 
the methylation levels in window-B for every target CpG sites. In this way, the 
prediction models no longer know the methylation level in the sequential 
neighboring region of a target CpG site, increasing the prediction difficulty. In 
order to observe how the number of Hi-C neighboring regions impact prediction 
performance, a “Hi-C range” was defined with the target CpG site as the center 
of it. The Hi-C pairs with one end fell into this “Hi-C range” and were collected; 
and the other end was used as the center of window-B. Only the Hi-C contacts 
whose two ends have a sequential distance longer than the “Hi-C range” were 
included so that only long-range spatial neighbors were kept.  
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Evaluation Methods 
Evaluation criteria: the specificity (Sp), sensitivity (Se), accuracy (Acc), 
and Matthews’s correlation coefficient (MCC) were used to evaluate prediction 
performance. These parameters were calculated using the following equations65: 
Sn = 1 −⁡
𝑁−
+
𝑁+
        (8) 
 
Sp = 1 −⁡
𝑁+
−
𝑁−
         (9) 
 
Acc = 1 −⁡
𝑁−
++𝑁+
−
𝑁++𝑁−
   (10) 
     
MCC = ⁡
1 − (
𝑁−
+
𝑁+
+
𝑁+
−
𝑁−)
√(1 +
𝑁+
− − 𝑁−+
𝑁+
)(1 +
𝑁−+ − 𝑁+
−
𝑁− )
 
 
                                                      (11) 
 
where 𝑁+is the total number of the positive samples (methylated 
samples), and 𝑁−
+ is the number of the positive samples incorrectly predicted as 
negative samples (un-methylated samples), 𝑁− is the total number of the 
negative samples, and 𝑁+
− is the number of negative samples incorrectly 
predicted as the positive samples.  
Receiver Operating Characteristic (ROC) curves for leave-one-out cross-
validation were plotted with different values of threshold µ, which was used as 
the cutoff for methylated and unmethylated classes based on the SVM output 
real-number value. 
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Leave-one-out Cross-validation (Benchmark 1) 
The performance of SVM model and SdAs were evaluated by the leave-
one-out cross-validation. For the prediction of methylation state of each CpG site, 
the rest of the CpG sites were used as training samples. For SdA, the rest of the 
samples were split so that 50% of the samples were used as fine-tuning set and 
50% as validation set. The same fine-tuning samples were also used in the pre-
training stage (unsupervised learning), in which the target values Y were not 
used. The final evaluation of the prediction performance was obtained by 
averaging the results from all round of cross-validation.  
The methylation value for each CpG site was indicated by the value of 
percentMeth from RRBS experiments. Methylation level of a CpG site is a 
continuous value ranging from 0 (un-methylated) to 1 (methylated). Because I 
tried to classify the methylation status of a CpG site into binary classes 
(methylation state), that is, either methylated or un-methylated, I incorporated two 
thresholds α and β to convert the continuous value of PercentMeth into binary 
classes. Specifically, if the PercentMeth value of a CpG site is larger than α, the 
CpG site is classified as methylated, and if the methylation level of a CpG site is 
less than β, the CpG site is classified as un-methylated (methylation-resistant). 
The threshold β was set first to 0.01, and then the threshold α was calculated 
based on β to ensure these two binary classes would have equal numbers of 
samples. Balancing the number of samples in each class avoids bias in training. 
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Blind Test on Chromosomes 21 and X (Benchmark 1) 
The chromosomes 1, 2, and 3 were used as training data sets because of 
their relatively larger size, and chromosomes 21 and X were selected as two 
independent blind testing data sets because of their smaller size and the possible 
inactivation of female X chromosome. 
Five-fold Cross-validation (Benchmark 2) 
In Benchmark 2, I eliminated the feature “Ave_meth” (methylation level in 
the neighboring region of target CpG sites) and added 74 PseTNC features 
(Table 15). I collected all the CpG sites with “PercentMeth” value in the RRBS 
experiment equal to 0 and assigned them as un-methylated samples; the CpG 
sites with >= 0.9 were used as positive samples. In this way, I collected in total 
559 positive samples and 1,959 negative samples. These samples were evenly 
split into five folds. For the training of SVM, down-sampling (cut samples from the 
majority class) was performed on the four training folds. The up-sampling 
technique (randomly picking up the same number of samples for the minority 
class) was performed for SdA in order to balance the positive and negative 
samples in the training folds. The data in the testing fold was not balanced. For 
SdAs, three folds were used as fine-tuning data (up-sampling balanced), one fold 
as validation (up-sampling balanced), and one fold as test (not balanced). 
Benchmark 2 was performed on chromosome 1 of the GM12878 cell line.  
In order to benchmark the contribution of unsupervised pre-training of 
SdAs, I randomly collected 2,330 samples in chromosome 1 with unknown target 
value. For every round in the 5-fold cross-validation and blind test with 
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chromosome 21, this data set was used as the pre-training sample for training 
SdAs. This 5-fold cross-validation was performed with multiple “Hi-C range” 
(definition see Machine Learning Features section).  
Blind test with Chromosome 21 (Benchmark 2) 
I collected 1,039 positive and 1,746 negative samples from chromosome 
21 in the same way as from chromosome 1, and randomly combined them with 
all the samples from chromosome 1 used in the 5-fold cross-validation. All of the 
randomly combined data set was split into five folds. For SVM, four folds were 
used to train the model and one for test. For SdAs, three folds were used as fine-
tuning, one fold for validation, and one for testing. The same un-labeled data set 
was used for unsupervised pre-training. No up-sampling or down-sampling was 
performed on any of the folds. Only 10K “Hi-C range” was used in this blind test 
stage 
Test with randomly selected windows (Benchmark 2) 
To benchmark the contributions of Hi-C related features, I replaced Hi-C 
based window-Bs with same-size random windows, which do not have any Hi-C 
contacts with the “Hi-C range” of a target CpG site. All the same features were 
generated on the random window as for Hi-C window-B.  
Parallelization of Feature Generation and SVM Classification 
A parallel algorithm was designed to reduce the execution time of feature 
generating and SVM-light classification. First, multiple processors simultaneously 
read the Hi-C contact files using MPI (Message Passing Interface), and then a 
parallel version of SVM-light was developed to make each processor perform 
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learning and classification simultaneously. This parallel algorithm was designed 
and tested on an early version of my methods that targeted on predicting 
average methylation level of a segment of the genome instead of each CpG site. 
However, the feature types and SVM classification are the same. Execution time 
decreased with the increase of number of processors (see the Results section). 
Statement for Experiments Involving Vertebrates and Human Subjects 
This research was conducted with purely computational methods and did 
not use any animals, human subjects, or tissue samples. This work did not 
conduct any wet lab biological experiments that used vertebrates, human 
subjects, or tissue samples. The data of all cell-lines were downloaded from the 
public database ENCODE that has already been previously published. 
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